| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 30.324 | 35.438 | 42.313 | 51.793 | 59.498 | 65.941 | 67.153 | 79.821 | 89.400 |
| Total Income - EUR | - | 30.324 | 35.438 | 42.313 | 51.793 | 59.498 | 65.941 | 67.153 | 79.821 | 89.467 |
| Total Expenses - EUR | - | 25.245 | 29.712 | 33.520 | 36.474 | 44.163 | 48.357 | 48.146 | 40.687 | 53.489 |
| Gross Profit/Loss - EUR | - | 5.079 | 5.726 | 8.793 | 15.319 | 15.335 | 17.584 | 19.007 | 39.134 | 35.978 |
| Net Profit/Loss - EUR | - | 4.775 | 5.372 | 8.372 | 14.801 | 14.777 | 16.924 | 18.336 | 38.336 | 33.294 |
| Employees | - | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Dr. Iordache Liliana Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 17.373 | 12.050 | 6.930 | 1.993 | 0 | 0 | 0 |
| Current Assets | - | 5.457 | 6.399 | 4.837 | 6.544 | 10.279 | 16.604 | 13.918 | 40.711 | 37.445 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 2.556 | 3.362 | 3.646 | 5.076 | 5.868 | 11.379 | 6.710 | 24.049 | 31.287 |
| Cash | - | 2.901 | 3.037 | 1.191 | 1.468 | 4.411 | 5.225 | 7.209 | 16.661 | 6.158 |
| Shareholders Funds | - | 4.556 | 5.486 | 8.415 | 14.851 | 14.826 | 16.973 | 11.748 | 38.384 | 33.342 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 901 | 914 | 13.795 | 3.743 | 2.382 | 1.624 | 2.170 | 2.327 | 4.103 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Dr. Iordache Liliana Srl